ASX - By Stock
|
HCT |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
a2zz
|
8 |
843 |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
8
|
843
|
0
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
a2zz
|
8 |
843 |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
8
|
843
|
0
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
a2zz
|
8 |
843 |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
8
|
843
|
1
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
a2zz
|
8 |
843 |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
8
|
843
|
1
|
|
ASX - By Stock
|
BIT |
Re:
No More CR until FULL RESULTS are available and better
|
|
a2zz
|
45 |
11K |
1 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
45
|
11K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
No More CR until FULL RESULTS are available and better
|
|
a2zz
|
45 |
11K |
1 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
45
|
11K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
No More CR until FULL RESULTS are available and better
|
|
a2zz
|
45 |
11K |
0 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
45
|
11K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
No More CR until FULL RESULTS are available and better
|
|
a2zz
|
45 |
11K |
12 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
45
|
11K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
No More CR until FULL RESULTS are available and better
|
|
a2zz
|
45 |
11K |
7 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
45
|
11K
|
7
|
|
ASX - By Stock
|
BIT |
No More CR until FULL RESULTS are available and better
|
|
a2zz
|
45 |
11K |
16 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
45
|
11K
|
16
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
a2zz
|
168 |
41K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
168
|
41K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
a2zz
|
168 |
41K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
168
|
41K
|
2
|
|
ASX - By Stock
|
BIT Biotech |
Re:
CR before results=poor results?
|
|
a2zz
|
26 |
6.7K |
12 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
26
|
6.7K
|
12
|
|
ASX - By Stock
|
BIT Biotech |
Re:
CR before results=poor results?
|
|
a2zz
|
26 |
6.7K |
6 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
26
|
6.7K
|
6
|
|
ASX - By Stock
|
BIT Biotech |
Re:
CR before results=poor results?
|
|
a2zz
|
26 |
6.7K |
9 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
26
|
6.7K
|
9
|
|
ASX - By Stock
|
BIT Biotech |
Re:
CR before results=poor results?
|
|
a2zz
|
26 |
6.7K |
8 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
26
|
6.7K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
a2zz
|
168 |
41K |
5 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
168
|
41K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
a2zz
|
168 |
41K |
9 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
168
|
41K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
a2zz
|
168 |
41K |
8 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
168
|
41K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
a2zz
|
168 |
41K |
2 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
168
|
41K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
a2zz
|
168 |
41K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
168
|
41K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
a2zz
|
168 |
41K |
0 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
168
|
41K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
How many weeks to go?
|
|
a2zz
|
1 |
746 |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1
|
746
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
a2zz
|
2.0K |
704K |
4 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
2.0K
|
704K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
a2zz
|
2.0K |
704K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
2.0K
|
704K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Due for a bounce?
|
|
a2zz
|
4 |
1.0K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
4
|
1.0K
|
6
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Request for Continued Voluntary Suspension
|
|
a2zz
|
5 |
1.2K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
5
|
1.2K
|
0
|
|
ASX - By Stock
|
BIT |
How many weeks to go?
|
|
a2zz
|
1 |
746 |
6 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1
|
746
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
297
|
96K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
a2zz
|
2.0K |
704K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
2.0K
|
704K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
a2zz
|
474 |
151K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
474
|
151K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT Chart
|
|
a2zz
|
20 |
4.1K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
20
|
4.1K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Jane Bell
|
|
a2zz
|
38 |
18K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
38
|
18K
|
2
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Request for Continued Voluntary Suspension
|
|
a2zz
|
5 |
1.2K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
5
|
1.2K
|
0
|
|
ASX - By Stock
|
HCT |
Re:
Ann: Request for Continued Voluntary Suspension
|
|
a2zz
|
5 |
1.2K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
5
|
1.2K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Jane Bell
|
|
a2zz
|
38 |
18K |
19 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
38
|
18K
|
19
|
|
ASX - By Stock
|
BIT |
Re:
BIT Chart
|
|
a2zz
|
20 |
4.1K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
20
|
4.1K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
297
|
96K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
prediction of share price
|
|
a2zz
|
1 |
750 |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
1
|
750
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
0 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
297
|
96K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
a2zz
|
549 |
173K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
549
|
173K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
297
|
96K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
a2zz
|
5.0K |
1.3M |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
5.0K
|
1.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
297
|
96K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
297
|
96K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
297
|
96K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
a2zz
|
5.0K |
1.3M |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
5.0K
|
1.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
297
|
96K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
7 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
297
|
96K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
a2zz
|
297 |
96K |
7 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
297
|
96K
|
7
|
|